26-A-15097-ACC IMPACT OF PCSK9 INHIBITORS (ALIROCUMAB AND EVOLOCUMAB) ON PATIENTS WITH CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) ON MAXIMAL STATIN THERAPY AND ADVANCED CHRONIC KIDNEY DISEASE (CKD): A PROPENSITY-MATCHED ANALYSIS

View at publisher Summarise with VIRAT
Authors: Efeturi Maxwell Okorigba, Avilash Mondal, Abdulraheem Eniola Hassan, Clara Nkongho Tabot Ntoung, Carlson Sama, Aisha Jamal, Binita Bhandari, Emmanuel Otabor, Olalekan Paul Olayiwola, Mobeen Zaka Haider, Amro Taha, Sudarshan Balla
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Chronic Kidney Disease and Diabetes Antiplatelet Therapy and Cardiovascular Diseases

Publication details

Journal / source
Journal of the American College of Cardiology
Volume
87
Issue
13
Pages
A275–A275
Publication date
27 March 2026
Language
EN